Skip to Content

Advanced Training in vaccinology for European and DC scientists in relation to PRD vaccines (ADVAC)

Work Package Leader

University of Geneva - Prof Paul-Henri Lambert


The objective of this work package is to generate training opportunities for PRD vaccine researchers by funding students from Europe as well as from developing countries (DC) who wish to attend the Advanced Training in Vaccinology (ADVAC) Course offered by Fondation Mérieux in Geneva, Switzerland.

Areas of training will relate to:

  1. Pre-clinical vaccine research (go and no-go decisions, safety assessment, immunological considerations etc.).
  2. Design and monitoring of clinical trials (ethical issues, calculation of size, monitoring and interpretation of results).
  3. Vaccine safety issues.
  4. Selection of new and appropriate vaccination strategies (immunological limitations, epidemiological and economic aspects etc.).
  5. Effective communication.

The training will also review advances regarding high priority PRD vaccines: malaria, tuberculosis, HIV/AIDS, diarrhoeal diseases, acute respiratory infections and emerging diseases. It has long been perceived to be of importance that people entering into a career in vaccine R&D be exposed to economic, epidemiological, and logistic issues that will, at a later stage, influence the development and real-life use of the new vaccines.

The course director is Prof Paul-Henri Lambert. The Fondation Mérieux  (Scientific Director: Dr Christophe Longuet) is responsible for administrative management, and the curriculum is under the supervision of the Center for Vaccinology and Neonatal. Immunology, University of Geneva (Prof Claire-Anne Siegrist).

The course is comprised of top-level lectures, followed by extensive interactive discussions, and specific exercises in small working groups. Care is taken to maintain a full independence from any influence of a commercial nature. English is the official language. This course is the basis for stimulating a large international, cooperation and to favour the development of vaccinology networks. The course is complemented by a follow-up alumni programme, including the establishment of a network based on a specific web forum and information system.

The annual course is normally restricted to a total of 60 participants, usually comprising of 30 participants from developing countries (mostly with fellowships covering all costs) and 30 participants from industrialised countries (about 20 from governmental agencies or academia, and 10 self-funded from industry). They are selected by an international Scientific Committee that reviews and ranks applications. The global faculty comprises of 50 to 60 leading experts in vaccinology.

This objective has reserved 10 places per year (for three years) for INYVAX-funded students. Selection will be made by the ADVAC Scientific Committee.


D4.1 First course: list of trainees and evaluation
D4.2 Second course: list of trainees and evaluation
D4.3 Third course: list of trainees and evaluation
D4.4 Modules of training